Doravirine — Drug Intelligence | 7 EU Trials

Filter these 7 trials by condition, phase, country and more.

7 Registered trials

1 Recruiting

4 Completed trials

8 Sponsors

8 Countries

Phase III

Phase II

Phase I/II

Phase IV

Phase III: 2 Phase II: 2 Phase I/II: 1 Phase IV: 2

Sponsors using this IMP

7 total

DORAL Pending

2024-513941-35-00 Phase I/II 3 countries Centre de Recherches et d’Etudes sur les Pathologies Infectieuses, Tropicales et…
Randomized Multicentric Proof-of-Concept Phase 2 Trial Doravirine in the Early Outpatient Management of West Nile Virus Infection in Patien… Pending

2025-521677-14-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
MODULO Recruiting

2024-515793-27-01 Phase III 1 country ANRS Maladies Infectieuses Emergentes; Centre De Recherches Et D'Etudes Sur La P…
Efficacy of doravirine + dolutegravir dual therapy in the context of antiretroviral therapy switch Ended

2023-509751-14-03 Phase II 1 country Chelsea And Westminster Hospital NHS Foundation Trust
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 ( ISLEND-… Ended

2024-514047-28-00 Phase III 4 countries Gilead Sciences Inc.
Impact of Doravirine in Liver Steatosis and Fibrosis in PLWH. A pilot, proof of concept study (DORALI Study) Ended

2023-504952-87-00 Phase IV 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…
Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Ended

2024-515487-31-00 Phase IV 5 countries Stichting Radboud universitair medisch centrum

Showing 1–7 of 7 trials